Tag: Metabolic Reprogramming

The Warburg Effect and the Hallmarks of Cancer

This conceptual review explores how the Warburg effect—characterized by cancer cells favoring aerobic glycolysis over oxidative phosphorylation—intersects with the established hallmarks of cancer. The authors argue that this metabolic reprogramming is not merely a consequence but a driver of tumorigenesis. The shift to glycolysis results in reduced ATP yield, compelling

Read More »

DCA and cancer

The article “Dichloroacetate (DCA) and Cancer: An Overview towards Clinical Applications” (Oxidative Medicine and Cellular Longevity, 2019, PMID: 31827705) reviews the potential of DCA in cancer therapy, discussing its mechanism of action in targeting cancer cell metabolism by shifting energy production from glycolysis to mitochondrial oxidation. It highlights DCA’s ability

Read More »